Join to View Full Profile
7979 Wurzbach RdSan Antonio, TX 78229
Phone+1 210-450-1143
Fax+1 210-450-0407
Dr. Lathrop is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2011 - 2014- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2007 - 2010
- The University of Texas Health Science Center at San AntonioClass of 2007
Certifications & Licensure
TX State Medical License 2009 - 2025
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Host Immune Response to Novel RNA COVID-19 Vaccination Start of enrollment: 2021 Feb 24
Publications & Presentations
PubMed
- Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors.Ranjit Banwait, Heidi Ko, Joel Michalek, Qianqian Liu, Kate Lathrop
International Journal of Cancer. 2025-04-15 - Genomic and transcriptomic landscape of HER2-low breast cancer.Rani Bansal, Tolulope Adeyelu, Andrew Elliott, Phillip Walker, Matias A Bustos
Breast Cancer Research and Treatment. 2025-01-01 - 8 citationsSacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial.Henriette U Balinda, William J Kelly, Virginia G Kaklamani, Kate I Lathrop, Marcela Mazo Canola
Nature Communications. 2024-08-07
Press Mentions
Risk-Reducing Surgeries Improve Survival for Younger Patients with Breast Cancer Who Are BRCA Carriers, Study FindsJanuary 25th, 2025- OlympiA Trial: Long-Term Benefits of Olaparib Confirmed in High-Risk Subgroup of Breast CancerJanuary 25th, 2025
- Imlunestrant Combo Improves PFS in Advanced Breast CancerDecember 11th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
